This article considers the challenges and potential benefits of combining the two. The nasal delivery of biologics offers considerable potential for both local and systemic action and for direct access to the brain and CNS to address currently unmet therapeutic need. The unique features of biologics are discussed with reference to the associated difficulties of nasal delivery and the benefits of partnership with experts such as Aptar Pharma is highlighted. Work on the development of vaccines and prophylactics for COVID-19 illustrates what is achievable.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
Nasal Casts, Tools to Enable Nasal Drug Delivery Development
Webinars, Pharmaceutical, Drug Delivery Innovations, Market Insights, Product Solutions
In Silico Modelling for Orally Inhaled Drug Development (OINDP)
Webinars, Pharmaceutical, Market Insights, Product Solutions, Innovation & Insights
Sustainable Propellants and Bioequivalence Innovation in OINDPs
Publications, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions
Intranasal Delivery of Monoclonal Antibodies via Dry Powder
Publications, Pharmaceutical, Product Solutions, Innovation & Insights, Drug Delivery Innovations
